ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Quality of Life of Older Patients Who Are Undergoing Treatment for Cancer and of Their Family Caregivers

This study is currently recruiting participants.
Verified by National Cancer Institute (NCI), April 2008

Sponsors and Collaborators: Case Comprehensive Cancer Center
National Cancer Institute (NCI)
Information provided by: National Cancer Institute (NCI)
ClinicalTrials.gov Identifier: NCT00255697
  Purpose

RATIONALE: Studying quality-of-life in patients having cancer treatment and in their caregivers may help identify the intermediate- and long-term effects of treatment on patients with cancer and on their caregivers.

PURPOSE: This clinical trial is studying quality of life of older patients who are undergoing treatment for cancer and of their family caregivers.


Condition Intervention
Psychosocial Effects/Treatment
Quality of Life
Unspecified Adult Solid Tumor, Protocol Specific
Procedure: psychosocial assessment and care
Procedure: quality-of-life assessment

MedlinePlus related topics:   Cancer    Caregivers   

U.S. FDA Resources

Study Type:   Observational
Official Title:   Quality of Life Study Registry for Persons With Cancer and Family Caregivers

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:
  • Functional status by Karnofsky and ECOG at baseline, 3 months, and 1 year
  • Co-morbidities by Charlson at baseline
  • Cognitive status by Short Orientation Concentration Memory Test at baseline, 3 months, and 1 year
  • Quality of Life (QOL) by SF-12 at baseline
  • QOL and Symptoms by Functional Assessment of Cancer Therapy-General (FACT-G) at baseline, 3 months, and 1 year
  • Spirituality by Functional Assessment of Chronic Illness Therapy (FACIT)-Sp at baseline, 3 months, and 1 year
  • Social Support by Shortened Social Support Scale at baseline, 3 months, and 1 year
  • Satisfaction with care by FACIT-TS-PS at 3 months and 1 year
  • Mood state by Profile of Mood States at baseline, 3 months, and 1 year
  • Optimism by Life Orientation Test at baseline
  • Caregiver Burden by Caregiver Reaction Assessment at baseline, 3 months, and 1 year

Secondary Outcome Measures:
  • Trends over time (mood state, satisfaction, symptoms, QOL, caregiver burden, and cognitive status) for patient and caregiver by the tools listed above at 3 months and 1 year

Study Start Date:   July 2005
Estimated Primary Completion Date:   July 2010 (Final data collection date for primary outcome measure)

Detailed Description:

OBJECTIVES:

  • Obtain quality of life and psychosocial data from older patients who are undergoing treatment for cancer and from their family caregivers.

OUTLINE: This is a pilot, cross-sectional study.

Patients undergo a 45-minute interview in person or by phone to provide demographic data and to complete quality of life questionnaires, including Functional Assessment of Cancer Therapy (FACT), Spiritual tool, Quality and Satisfaction with Treatment (QUEST), and Profile of Mood State (POMS), at baseline and at 3 and 12 months. Caregivers undergo a 20- to 30-minute interview in person or by phone to provide demographic data and complete quality of life questionnaires, including the Caregiver Reaction Assessment (CRA), Quest, and POMS, at baseline and at 3 and 12 months. Caregivers complete the Quality of Death and Dying (QODD) questionnaire 2-3 months after the patient's death.

PROJECTED ACCRUAL: Not specified

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

DISEASE CHARACTERISTICS:

  • Patient:

    • Confirmed diagnosis of any type of cancer
    • Undergoing cancer treatment at Ireland Cancer Center
  • Caregiver:

    • Identified family caregiver of a patient diagnosed with cancer
  • Patient and caregiver may participate regardless of whether the other person agrees to participate or not

PATIENT CHARACTERISTICS:

Performance status

  • ECOG 0-3 (patient)

Life expectancy

  • Not specified

Hematopoietic

  • Not specified

Hepatic

  • Not specified

Renal

  • Not specified

Other

  • Able to speak and comprehend English
  • Cognitively competent to be interviewed (patient)

PRIOR CONCURRENT THERAPY: Not specified

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00255697

Locations
United States, Ohio
Case Comprehensive Cancer Center     Recruiting
      Cleveland, Ohio, United States, 44106-5065
      Contact: Clinical Trials Office - Case Comprehensive Cancer Center     800-641-2422        

Sponsors and Collaborators
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Investigators
Principal Investigator:     Barbara Daly, PhD, RN     Case Comprehensive Cancer Center    
  More Information

Clinical trial summary from the National Cancer Institute's PDQ® database  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   CDR0000448642, CASE-8Z05
First Received:   November 18, 2005
Last Updated:   July 23, 2008
ClinicalTrials.gov Identifier:   NCT00255697
Health Authority:   Unspecified

Keywords provided by National Cancer Institute (NCI):
quality of life  
psychosocial effects/treatment  
unspecified adult solid tumor, protocol specific  

Study placed in the following topic categories:
Quality of Life

ClinicalTrials.gov processed this record on August 28, 2008




Links to all studies - primarily for crawlers